The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Spear Bio Forms Strategic Partnership with Bio-Techne to Enhance Neurodegenerative Disease Research.
Jul 16, 2025•11 months ago
Contract Type
partnership
WoburnBiotechnology
Description
Spear Bio has announced a strategic distribution partnership with Bio-Techne to expand global access to its SPEAR UltraDetect™ immunoassays. The collaboration aims to improve early detection of critical biomarkers for neurodegenerative diseases.
Company Information
Company
Spear Bio
Location
Woburn, Massachusetts, United States
About
Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar level from sub-microliter sample volume. Spear Bio is focused on leveraging its technology’s unprecedented sensitivity to transform protein research and early disease diagnosis.